Related Experiment Video

Updated: Mar 12, 2026

Identification of Inositol Phosphate or Phosphoinositide Interacting Proteins by Affinity Chromatography Coupled to Western Blot or Mass Spectrometry
08:07

Identification of Inositol Phosphate or Phosphoinositide Interacting Proteins by Affinity Chromatography Coupled to Western Blot or Mass Spectrometry

Published on: July 26, 2019

9.0K

The Hidden Conundrum of Phosphoinositide Signaling in Cancer

Narendra Thapa1, Xiaojun Tan2, Suyong Choi1

  • 1University of Wisconsin-Madison School of Medicine and Public Health, 1300 University Avenue, Madison, WI 53706, USA.

Trends in Cancer
|November 8, 2016
PubMed

Insights

Phosphatidylinositol 4,5-bisphosphate (PI(4,5)P2) is a key lipid messenger in cancer, regulating cell migration and invasion. This review highlights its role beyond a PI3K substrate, emphasizing phosphatidylinositol phosphate kinases (PIPKs) in cancer signaling.

Area of Science:

  • Oncology
  • Cell Biology
  • Biochemistry

Background:

  • The phosphoinositide 3-kinase (PI3K)/Akt pathway is central to cancer signaling, primarily focusing on PI(3,4,5)P3 generation.
  • Phosphatidylinositol 4,5-bisphosphate (PI(4,5)P2) is increasingly recognized as a critical lipid messenger involved in various cancer cell processes.
  • Phosphatidylinositol phosphate (PIP) kinases (PIPKs) are key enzymes responsible for generating PI(4,5)P2.

Purpose of the Study:

  • To review the significance of the phosphoinositide signaling axis in cancer.
  • To emphasize the role of PI(4,5)P2 and PIP kinases as central regulators in cancer signaling.
  • To explore the interaction of PI(4,5)P2 with cytoskeletal proteins in regulating cancer cell metastasis.

Main Methods:

  • Literature review of phosphoinositide signaling in cancer.
  • Analysis of the role of PI(4,5)P2 and PIP kinases in cancer.
  • Examination of PI(4,5)P2 interactions with cytoskeletal proteins.

Main Results:

  • PI(4,5)P2 functions as a crucial lipid messenger in cancer, not just a substrate for PI3K and phospholipase C (PLC).
  • PI(4,5)P2 and PIP kinases act as proximal signaling nodes.
  • PI(4,5)P2 interactions with cytoskeletal proteins are vital for regulating cancer cell migration and invasion.

Conclusions:

  • PI(4,5)P2 and its generating enzymes, PIPKs, are pivotal in cancer cell signaling and metastasis.
  • Understanding PI(4,5)P2's role offers new therapeutic targets for cancer treatment.
  • The interaction between PI(4,5)P2 and the cytoskeleton is critical for understanding tumor cell invasiveness.
Keywords:
AktPI(3,4,5)P3PI(4,5)P2PI3KPIPKIγ

More Related Videos

Radiolabeling and Quantification of Cellular Levels of Phosphoinositides by High Performance Liquid Chromatography-coupled Flow Scintillation10:52

Radiolabeling and Quantification of Cellular Levels of Phosphoinositides by High Performance Liquid Chromatography-coupled Flow Scintillation

Published on: January 6, 2016

10.9K
Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment11:13

Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment

Published on: June 9, 2023

2.4K

Related Concept Videos

Phosphoinositides and PIPs01:42

Phosphoinositides and PIPs

Phosphoinositides are a group of phospholipids containing a glycerol backbone with two fatty acid chains and a phosphate attached to a myoinositol sugar ring. The inositol head group extends into the cytoplasm, where it is modified by adding phosphate groups to form phosphatidylinositol phosphates or PIPs.
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
10.4K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
6.1K
IP3/DAG Signaling Pathway01:11

IP3/DAG Signaling Pathway

Membrane lipids such as phosphatidylinositol (PI) are precursors for several membrane-bound and soluble second messengers. Specific kinases phosphorylate PI and produce phosphorylated inositol phospholipids. One such inositol phospholipids are the  phosphatidylinositol-4,5 bisphosphate [PI(4,5)P2], present in the inner half of the lipid bilayer. Upon ligand binding, GPCR stimulates Gq proteins to turn on phospholipase Cꞵ. Activated phospholipase Cꞵ cleaves PI(4,5)P2 and...
15.5K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.7K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.0K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

1.6K